Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Recommendation of “Buy” by Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been assigned a consensus recommendation of “Buy” from the fifteen analysts that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, eleven have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $24.79.

Several analysts recently issued reports on the company. JPMorgan Chase & Co. raised their target price on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Barclays increased their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. KeyCorp assumed coverage on Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Robert W. Baird raised their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 26th. Finally, Truist Financial lifted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th.

Institutional Investors Weigh In On Privia Health Group

Hedge funds have recently bought and sold shares of the business. Victory Capital Management Inc. boosted its holdings in Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after acquiring an additional 143,446 shares in the last quarter. GAMMA Investing LLC grew its position in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Privia Health Group during the 3rd quarter valued at about $1,206,000. Peregrine Capital Management LLC lifted its stake in shares of Privia Health Group by 11.5% in the second quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock worth $5,461,000 after buying an additional 32,311 shares in the last quarter. Finally, BlackBarn Capital Partners LP grew its holdings in shares of Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after buying an additional 200,000 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Up 0.3 %

Shares of Privia Health Group stock opened at $20.96 on Friday. The company’s fifty day simple moving average is $19.96 and its two-hundred day simple moving average is $19.01. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $24.30. The firm has a market cap of $2.52 billion, a PE ratio of 209.62, a price-to-earnings-growth ratio of 5.49 and a beta of 0.83.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.